Elevated levels of C-reactive protein as a risk factor for Metabolic Syndrome in Indians

Atherosclerosis

Volumn 220, Issue 1, 2012, Pages 275-281

  Mahajan, Anubha ^a   Jaiswal, Alok ^a   Tabassum, Rubina ^a   Podder, Avijit ^a   Ghosh, Saurabh ^b   Madhu, S V ^c   Mathur, Sandeep K ^d   Tandon, Nikhil ^e   Bharadwaj, Dwaipayan ^a  

^a CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c UNIVERSITY COLLEGE OF MEDICAL SCIENCES   (India)

^d SMS MEDICAL COLLEGE   (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

HsCRP; Indians; Metabolic Syndrome

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; DYSLIPIDEMIA; FEMALE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INDIAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; WAIST CIRCUMFERENCE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INDIA; INSULIN RESISTANCE; LINEAR MODELS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; ODDS RATIO; RISK ASSESSMENT; RISK FACTORS; UP-REGULATION; URBAN POPULATION;

EID: 84155167910     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2011.10.031     Document Type: Article

References (28)

1. Lakka H.M., Laaksonen D.E., Lakka T.A., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002, 288(21):2709-2716.
2. Ridker P.M., Buring J.E., Cook N.R., et al. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 2003, 107(3):391-397.
3. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004, 350(14):1387-1397.
4. Pradhan A.D., Manson J.E., Rifai N., et al. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286(3):327-334.
5. Rutter M.K., Meigs J.B., Sullivan L.M., et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004, 110(4):380-385.
6. Wilson P.W.F., D'Agostino R.B., Parise H., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112(20):3066-3072.
7. Ramachandran A., Mary S., Yamuna A., et al. High prevalence of diabetes and cardiovascular risk factors associated with urbanization in India. Diabetes Care 2008, 31(5):893-898.
8. Misra A., Wasir J.S., Pandey R.M. An evaluation of candidate definitions of the metabolic syndrome in adult Asian Indians. Diabetes Care 2005, 28(2):398-403.
9. Bharadwaj D., Stein M.P., Volzer M., et al. The major receptor for C-reactive protein on leukocytes is Fcγ receptor II. J Exp Med 1999, 190(4):585-590.
10. Bharadwaj D., Mold C., Markham E., et al. Serum amyloid P component binds to Fc gamma receptors and opsonizes particles for phagocytosis. J Immunol 2001, 166(11):6735-6741.
11. Ye X., Yu Z., Li H., et al. Distributions of C-reactive protein and its association with metabolic syndrome in middle-aged and older Chinese people. J Am Coll Cardiol 2007, 49(17):798-805.
12. Mahadik S.R., Deo S.S., Mehtalia S.D. Relation of C-reactive protein with the components of metabolic syndrome in Asian Indian subjects. Diabetes Metab Syndr Res Rev 2008, 2(1):29-35.
13. Forouhi N.G., Sattar N., McKeigue P.M. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001, 25(9):1327-1331.
14. Festa A., Dágostino R., Howard G., et al. Chronic subclinical inflammation as a part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102(1):42-47.
15. Frohlich M., Imhof A., Berg G., et al. Association of C-reactive protein and features of metabolic syndrome: a population based study. Diabetes Care 2000, 23(12):1835-1839.
16. Chambers J.C., Eda S., Bassett P., et al. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001, 104(2):145-150.
17. Mahajan A., Tabassum R., Chavali S., et al. High-sensitivity C-reactive protein levels and type 2 diabetes in urban North Indians. J Clin Endocrinol Metab 2009, 94(6):2123-2127.
18. Expert committee on the diagnosis and classification of diabetes mellitus Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003, 26(Suppl. 1):S5-S20.
19. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement: executive summary. Circulation 2005, 112(17):2735-2752.
20. Tabassum R., Chavali S., Dwivedi O.P., et al. Genetic variants of FOXA2: risk of type 2 diabetes and effect on metabolic traits in North Indians. J Hum Genet 2008, 53(11-12):957-965.
21. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419.
22. Pearson T.A., Mensah G.A., Alexander R.W., et al. Centers for Disease Control and Prevention; American Heart Association: markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
23. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365(9468):1415-1428.
24. Kelley-Hedgepeth A., Lloyd-Jones D.M., Colvin A., et al. Ethnic differences in C-reactive protein concentrations. Clin Chem 2008, 54(6):1027-1037.
25. Chandalia M., Cabo-Chan A.V., Devaraj S., et al. Elevated plasma high-sensitivity C-reactive protein concentrations in Asian Indians living in the United States. J Clin Endocrinol Metab 2003, 88(8):3773-3776.
26. Khera A., McGuire D.K., Murphy S.A., et al. Race and gender differences in C-reactive protein levels. J Am Coll Cardiol 2005, 46(3):464-469.
27. Anand S.S., Razak F., Yi Q., et al. C-reactive protein as a screening test for cardiovascular risk in a multiethnic population. Arterioscler Thromb Vasc Biol 2004, 24(8):1509-1515.
28. Albert M.A., Glynn R.J., Buring J., et al. C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol 2004, 93(10):1238-1242.